Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

NCT01288326 · Completed

Last updated 2026-05-28

This study observes how well and safely the medication liraglutide works to lower blood sugar levels in adults with type 2 diabetes.

Status Completed The study has finished.

Type Observational

Participants 254 people

Who can join all sexes

Timeline Started 2011-02 · est. completion 2013-03

Where 1 site · Belgium

What this study is testing ClinicalTrials.gov NCT01288326 ↗

Description as written by the study sponsor.

The study is conducted in Europe. The aim of this observational study is to assess glycaemic control while using liraglutide under normal clinical practice conditions in Belgium.

Treatments tested

liraglutide Drug

Liraglutide will be prescribed and titrated (individually adjusted) by the treating physician.

Main thing measured	Percentage of participants with a decrease in HbA1c (glycosylated haemoglobin A1c) of at least 1%
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01288326 ↗